Canada's generic drugs: The basis for trust in their clinical efficacy
Jake Thiessen opened The Value of Generic Drugs Symposium with a discussion on the safety of generic drugs.
- September 11, 2014 September 13, 2019
- 10:56
Jake Thiessen opened The Value of Generic Drugs Symposium with a discussion on the safety of generic drugs.
Jim Keon, president of the Canadian Generic Pharmaceutical Association, shared recent data with symposium attendees on the use of generic medicines in Canada and the…
Download the PDF to find out more about this issue The professional world is going through a profound change. Employees who take care of both…
Investors are also showing renewed love for Asia - aside from Japan, Asian emerging markets have drawn investors’ attention as China’s growth outlook improves. That’s…
Panel discusses how crisis changed plan sponsors' view of risk management.
Gold exchange-traded funds (ETFs) lose their predictive power, leveraged gold ETFs under perform, and other must-read stories about ETFs that track this bright, shiny metal.
Download the PDF to read more Participants at this year’s Canadian Leadership Council on Drug Plan Partnerships are taking steps toward new alliances in order…
From a slave trade response to thematic investing, SRI has come a long way.
Canada’s biggest investors haven’t wholeheartedly embraced exchange-traded funds (ETFs), but that could be changing, according to a new survey of institutional ETF use by Greenwich…
Why your stress test needs to look forward, not back.
It’s been years now since Japan first initiated its plan to juice up its economy by buying domestic exchange-traded funds (ETFs). Back in 2010, the…
Download the PDF to read more Plan sponsors in Canada have reaped the benefits of lower prices and increased availability of generic prescription medicines over…
“I can’t believe it’s almost over!” That's the universal lament I’ve been hearing ever since the calendar ticked over to August 1. Back-to-school ads are…